# The Study Will Evaluate the Effect of AZD9164 in Patients With Chronic Obstructive Pulmonary Disease

> **NCT00939211** · PHASE2 · COMPLETED · sponsor: **AstraZeneca** · enrollment: 25 (actual)

## Conditions studied

- Chronic Obstructive Pulmonary Disease

## Interventions

- **DRUG:** AZD9164
- **DRUG:** Tiotropium
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00939211
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-06
- **Primary completion:** 2009-11
- **Final completion:** 2009-11
- **Target enrollment:** 25 (ACTUAL)
- **Last updated:** 2011-08-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00939211

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00939211, "The Study Will Evaluate the Effect of AZD9164 in Patients With Chronic Obstructive Pulmonary Disease". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT00939211. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*